If you had looked at Twist Bioscience in late 2025, the headlines were about ongoing losses, customer concentration risk, and concerns that DNA synthesis was becoming a commodity. For Twist Bioscience...
Source LinkIf you had looked at Twist Bioscience in late 2025, the headlines were about ongoing losses, customer concentration risk, and concerns that DNA synthesis was becoming a commodity. For Twist Bioscience...
Source Link
Comments